Lymph node ratio is a critical prognostic predictor in gastric cancer treated with S-1 chemotherapy

Background S-1 is an oral anticancer drug widely used in postoperative adjuvant therapy for patients in Japan with stage II/III gastric cancer. Candidates for more intense adjuvant treatments need to be identified, particularly among patients with stage III cancer. Methods Univariate and multivariat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2014, Vol.17 (1), p.67-75
Hauptverfasser:	Ema, Akira, Yamashita, Keishi, Sakuramoto, Shinich, Wang, Guoqin, Mieno, Hiroaki, Nemoto, Masayuki, Shibata, Tomotaka, Katada, Natsuya, Kikuchi, Shiro, Watanabe, Masahiko
Format:	Artikel
Sprache:	eng
Schlagworte:	Abdominal Surgery Adenocarcinoma - drug therapy Adenocarcinoma - mortality Adenocarcinoma - pathology Adenocarcinoma - surgery Aged Cancer Research Chemotherapy, Adjuvant Drug Combinations Female Gastric cancer Gastroenterology Humans Japan Lymph Node Excision Lymph Nodes - pathology Lymphatic Metastasis - pathology Male Medicine Medicine & Public Health Middle Aged Multivariate Analysis Neoplasm Staging Oncology Original Article Oxonic Acid - therapeutic use Prognosis Stomach Neoplasms - drug therapy Stomach Neoplasms - mortality Stomach Neoplasms - pathology Stomach Neoplasms - surgery Surgical Oncology Tegafur - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!